Related Articles
EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine‑resistant breast cancer cells
Mitogen-activated protein kinase phosphatase 1 is involved in tamoxifen resistance in MCF7 cells
Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells